Raymond James & Associates Acquires 234,322 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Raymond James & Associates lifted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 29.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,021,226 shares of the medical instruments supplier's stock after acquiring an additional 234,322 shares during the quarter. Raymond James & Associates owned 0.48% of DENTSPLY SIRONA worth $36,345,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Macquarie Group Ltd. lifted its stake in DENTSPLY SIRONA by 3.2% in the 2nd quarter. Macquarie Group Ltd. now owns 8,879 shares of the medical instruments supplier's stock valued at $318,000 after buying an additional 274 shares in the last quarter. Beach Investment Counsel Inc. PA raised its holdings in DENTSPLY SIRONA by 1.4% in the 4th quarter. Beach Investment Counsel Inc. PA now owns 22,125 shares of the medical instruments supplier's stock valued at $787,000 after acquiring an additional 306 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. raised its holdings in DENTSPLY SIRONA by 5.4% in the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 6,950 shares of the medical instruments supplier's stock valued at $237,000 after acquiring an additional 359 shares during the last quarter. Kentucky Retirement Systems Insurance Trust Fund raised its holdings in DENTSPLY SIRONA by 4.9% in the 3rd quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 7,721 shares of the medical instruments supplier's stock valued at $219,000 after acquiring an additional 360 shares during the last quarter. Finally, VisionPoint Advisory Group LLC raised its holdings in DENTSPLY SIRONA by 104.2% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier's stock valued at $26,000 after acquiring an additional 395 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Stock Down 0.4 %

Shares of XRAY stock traded down $0.12 on Friday, hitting $33.19. The company's stock had a trading volume of 2,604,965 shares, compared to its average volume of 2,416,624. The stock has a market capitalization of $6.88 billion, a price-to-earnings ratio of -53.53, a P/E/G ratio of 1.34 and a beta of 0.99. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.38 and a quick ratio of 0.95. DENTSPLY SIRONA Inc. has a fifty-two week low of $26.27 and a fifty-two week high of $43.24. The firm's fifty day moving average price is $33.67 and its 200-day moving average price is $33.16.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share for the quarter, topping analysts' consensus estimates of $0.43 by $0.01. The firm had revenue of $1.01 billion during the quarter, compared to analyst estimates of $972.61 million. DENTSPLY SIRONA had a negative net margin of 3.33% and a positive return on equity of 11.14%. The business's revenue was up 3.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.46 EPS. Research analysts anticipate that DENTSPLY SIRONA Inc. will post 2.05 EPS for the current year.

DENTSPLY SIRONA Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 12th. Shareholders of record on Friday, March 29th will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 1.93%. This is a boost from DENTSPLY SIRONA's previous quarterly dividend of $0.14. The ex-dividend date of this dividend is Wednesday, March 27th. DENTSPLY SIRONA's dividend payout ratio is currently -103.22%.

Wall Street Analyst Weigh In

A number of research firms have recently commented on XRAY. Needham & Company LLC restated a "buy" rating and set a $42.00 price objective on shares of DENTSPLY SIRONA in a report on Thursday, February 29th. Leerink Partnrs reiterated an "outperform" rating on shares of DENTSPLY SIRONA in a report on Monday, February 26th. Barrington Research restated an "outperform" rating and set a $41.00 target price on shares of DENTSPLY SIRONA in a research note on Friday, March 1st. StockNews.com upgraded DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Friday, January 19th. Finally, SVB Leerink initiated coverage on DENTSPLY SIRONA in a research note on Monday, February 26th. They issued an "outperform" rating and a $42.00 price target for the company. Three equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, DENTSPLY SIRONA has an average rating of "Moderate Buy" and a consensus price target of $39.50.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.